{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:34:36Z","timestamp":1790130876257,"version":"4.0.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100019593","name":"Saluda Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s40122-024-00628-z","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T07:02:04Z","timestamp":1719903724000},"page":"1119-1136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Durability of Evoked Compound Action Potential (ECAP)-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) in a Real-World European Chronic Pain Population"],"prefix":"10.1007","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct05272137","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0188-0893","authenticated-orcid":false,"given":"Harold","family":"Nijhuis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Willem","family":"Kallewaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"van de Minkelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem-Jan","family":"Hofst\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Elzinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippa","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isma\u00efl","family":"G\u00fcltuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Almac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesan","family":"Baranidharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Nikolic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Gulve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Vesper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birte E.","family":"Dietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave","family":"Mugan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J. P. M.","family":"Huygen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,2]]},"reference":[{"issue":"3","key":"628_CR1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1213\/00000539-196705000-00009","volume":"46","author":"CN Shealy","year":"1967","unstructured":"Shealy CN, Taslitz N, Mortimer JT, Becker DP. Electrical inhibition of pain: experimental evaluation. Anesth Analg. 1967;46(3):299\u2013305.","journal-title":"Anesth Analg"},{"issue":"1\u20132","key":"628_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.pain.2007.07.028","volume":"132","author":"K Kumar","year":"2007","unstructured":"Kumar K, et al. Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain. 2007;132(1\u20132):179\u201388.","journal-title":"Pain"},{"issue":"2","key":"628_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S1474-4422(19)30414-4","volume":"19","author":"N Mekhail","year":"2020","unstructured":"Mekhail N, et al. Long-term safety and efficacy of closed-loop spinal cord stimulation to treat chronic back and leg pain (Evoke): a double-blind, randomised, controlled trial. Lancet Neurol. 2020;19(2):123\u201334. https:\/\/doi.org\/10.1016\/S1474-4422(19)30414-4.","journal-title":"Lancet Neurol"},{"key":"628_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/ner.13267","author":"RV Duarte","year":"2020","unstructured":"Duarte RV, Soliday N, Leitner A, Taylor RS. Health-related quality of life associated with pain health states in spinal cord stimulation for chronic neuropathic pain. Neuromodul Technol Neural Interface. 2020. https:\/\/doi.org\/10.1111\/ner.13267.","journal-title":"Neuromodul Technol Neural Interface"},{"issue":"11","key":"628_CR5","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1097\/j.pain.0000000000002262","volume":"162","author":"RV Duarte","year":"2021","unstructured":"Duarte RV, et al. Spinal cord stimulation for the management of painful diabetic neuropathy: a systematic review and meta-analysis of individual patient and aggregate data. Pain. 2021;162(11):2635\u201343. https:\/\/doi.org\/10.1097\/j.pain.0000000000002262.","journal-title":"Pain"},{"issue":"1","key":"628_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/ner.12349","volume":"19","author":"S Eldabe","year":"2016","unstructured":"Eldabe S, et al. The effectiveness and cost-effectiveness of spinal cord stimulation for refractory angina (RASCAL study): a pilot randomized controlled trial: SCS for refractory angina (RASCAL study). Neuromodul Technol Neural Interface. 2016;19(1):60\u201370. https:\/\/doi.org\/10.1111\/ner.12349.","journal-title":"Neuromodul Technol Neural Interface"},{"issue":"6","key":"628_CR7","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1001\/jamaneurol.2021.0538","volume":"78","author":"EA Petersen","year":"2021","unstructured":"Petersen EA, et al. Effect of high-frequency (10-kHz) spinal cord stimulation in patients with painful diabetic neuropathy: a randomized clinical trial. JAMA Neurol. 2021;78(6):687\u201398.","journal-title":"JAMA Neurol"},{"issue":"3","key":"628_CR8","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.pain.2011.11.023","volume":"153","author":"JL Parker","year":"2012","unstructured":"Parker JL, Karantonis DM, Single PS, Obradovic M, Cousins MJ. Compound action potentials recorded in the human spinal cord during neurostimulation for pain relief. Pain. 2012;153(3):593\u2013601. https:\/\/doi.org\/10.1016\/j.pain.2011.11.023.","journal-title":"Pain"},{"issue":"4","key":"628_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/ner.12053","volume":"16","author":"JL Parker","year":"2013","unstructured":"Parker JL, et al. Electrically evoked compound action potentials recorded from the sheep spinal cord. Neuromodulation. 2013;16(4):295\u2013303. https:\/\/doi.org\/10.1111\/ner.12053. (discussion 303).","journal-title":"Neuromodulation"},{"key":"628_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/papr.13008","author":"C Brooker","year":"2021","unstructured":"Brooker C, et al. ECAP-controlled closed-loop spinal cord stimulation efficacy and opioid reduction over 24-months: final results of the prospective, multicenter, open-label Avalon study. Pain Pract. 2021. https:\/\/doi.org\/10.1111\/papr.13008.","journal-title":"Pain Pract"},{"issue":"3","key":"628_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1001\/jamaneurol.2021.4998","volume":"79","author":"N Mekhail","year":"2022","unstructured":"Mekhail N, et al. Durability of clinical and quality-of-life outcomes of closed-loop spinal cord stimulation for chronic back and leg pain: a secondary analysis of the evoke randomized clinical trial. JAMA Neurol. 2022;79(3):251\u201360. https:\/\/doi.org\/10.1001\/jamaneurol.2021.4998.","journal-title":"JAMA Neurol"},{"key":"628_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyaa003","author":"M Russo","year":"2020","unstructured":"Russo M, et al. Sustained long-term outcomes with closed-loop spinal cord stimulation: 12-month results of the prospective, multicenter, open-label Avalon study. Neurosurgery. 2020. https:\/\/doi.org\/10.1093\/neuros\/nyaa003.","journal-title":"Neurosurgery"},{"key":"628_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurom.2022.11.011","author":"RM Levy","year":"2023","unstructured":"Levy RM, et al. Holistic treatment response: an international expert panel definition and criteria for a new paradigm in the assessment of clinical outcomes of spinal cord stimulation. Neuromodul Technol Neural Interface. 2023. https:\/\/doi.org\/10.1016\/j.neurom.2022.11.011.","journal-title":"Neuromodul Technol Neural Interface"},{"key":"628_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/rapm-2023-104751","author":"NA Mekhail","year":"2023","unstructured":"Mekhail NA, et al. ECAP-controlled closed-loop versus open-loop SCS for the treatment of chronic pain: 36-month results of the EVOKE blinded randomized clinical trial. Reg Anesth Pain Med. 2023. https:\/\/doi.org\/10.1136\/rapm-2023-104751.","journal-title":"Reg Anesth Pain Med"},{"issue":"12","key":"628_CR15","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1093\/pm\/pnx241","volume":"18","author":"J De Andres","year":"2017","unstructured":"De Andres J, et al. Prospective, randomized blind effect-on-outcome study of conventional vs high-frequency spinal cord stimulation in patients with pain and disability due to failed back surgery syndrome. Pain Med Malden Mass. 2017;18(12):2401\u201321. https:\/\/doi.org\/10.1093\/pm\/pnx241.","journal-title":"Pain Med Malden Mass"},{"issue":"1","key":"628_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/ner.12698","volume":"21","author":"T Deer","year":"2018","unstructured":"Deer T, et al. Success using neuromodulation with BURST (SUNBURST) study: results from a prospective, randomized controlled trial using a novel burst waveform. Neuromodul Technol Neural Interface. 2018;21(1):56\u201366. https:\/\/doi.org\/10.1111\/ner.12698.","journal-title":"Neuromodul Technol Neural Interface"},{"issue":"4","key":"628_CR17","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/ALN.0000000000000774","volume":"123","author":"L Kapural","year":"2015","unstructured":"Kapural L, et al. Novel 10-khz high-frequency therapy (HF10 therapy) is superior to traditional low-frequency spinal cord stimulation for the treatment of chronic back and leg pain: the SENZA-RCT randomized controlled trial. Anesthesiology. 2015;123(4):851\u201360. https:\/\/doi.org\/10.1097\/ALN.0000000000000774.","journal-title":"Anesthesiology"},{"issue":"7","key":"628_CR18","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1097\/j.pain.0000000000002204","volume":"162","author":"N Katz","year":"2021","unstructured":"Katz N, et al. Research design considerations for randomized controlled trials of spinal cord stimulation for pain: initiative on methods, measurement, and pain assessment in clinical trials\/Institute of Neuromodulation\/International Neuromodulation Society recommendations. Pain. 2021;162(7):1935\u201356. https:\/\/doi.org\/10.1097\/j.pain.0000000000002204.","journal-title":"Pain"},{"issue":"6","key":"628_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/hast.779","volume":"47","author":"JL Schwartz","year":"2017","unstructured":"Schwartz JL. Real-world evidence, public participation, and the FDA. Hastings Cent Rep. 2017;47(6):7\u20138.","journal-title":"Hastings Cent Rep"},{"issue":"1","key":"628_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurom.2021.10.015","volume":"25","author":"TR Deer","year":"2022","unstructured":"Deer TR, et al. The Neurostimulation Appropriateness Consensus Committee (NACC): recommendations for surgical technique for spinal cord stimulation. Neuromodul Technol Neural Interface. 2022;25(1):1\u201334.","journal-title":"Neuromodul Technol Neural Interface"},{"key":"628_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/rapm-2024-105346","author":"L Muller","year":"2024","unstructured":"Muller L, et al. First evidence of a biomarker-based dose-response relationship in chronic pain using physiological closed-loop spinal cord stimulation. Reg Anesth Pain Med. 2024. https:\/\/doi.org\/10.1136\/rapm-2024-105346.","journal-title":"Reg Anesth Pain Med"},{"key":"628_CR22","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1109\/TNSRE.2023.3335100","volume":"31","author":"PS Single","year":"2023","unstructured":"Single PS, Scott JB, Mugan D. Measures of dosage for spinal-cord electrical stimulation: review and proposal. IEEE Trans Neural Syst Rehabil Eng. 2023;31:4653\u201360.","journal-title":"IEEE Trans Neural Syst Rehabil Eng"},{"issue":"4","key":"628_CR23","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/pm\/pnab015","volume":"22","author":"N Christelis","year":"2021","unstructured":"Christelis N, et al. Persistent spinal pain syndrome: a proposal for failed back surgery syndrome and ICD-11. Pain Med. 2021;22(4):807\u201318. https:\/\/doi.org\/10.1093\/pm\/pnab015.","journal-title":"Pain Med"},{"issue":"3","key":"628_CR24","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1049\/htl.2019.0110","volume":"7","author":"J Parker","year":"2020","unstructured":"Parker J, Karantonis D, Single P. Hypothesis for the mechanism of action of ECAP-controlled closed-loop systems for spinal cord stimulation. Healthc Technol Lett. 2020;7(3):76\u201380. https:\/\/doi.org\/10.1049\/htl.2019.0110.","journal-title":"Healthc Technol Lett"},{"issue":"5","key":"628_CR25","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s40122-023-00540-y","volume":"12","author":"HJ Nijhuis","year":"2023","unstructured":"Nijhuis HJ, Hofst\u00e9 W-J, Krabbenbos IP, Dietz BE, Mugan D, Huygen F. First report on real-world outcomes with evoked compound action potential (ECAP)-controlled closed-loop spinal cord stimulation for treatment of chronic pain. Pain Ther. 2023;12(5):1221\u201333.","journal-title":"Pain Ther"},{"issue":"1","key":"628_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s42234-023-00134-1","volume":"10","author":"EM Versantvoort","year":"2024","unstructured":"Versantvoort EM, Dietz BE, Mugan D, Vuong QC, Luli S, Obara I. Evoked compound action potential (ECAP)-controlled closed-loop spinal cord stimulation in an experimental model of neuropathic pain in rats. Bioelectron Med. 2024;10(1):2.","journal-title":"Bioelectron Med"},{"issue":"1","key":"628_CR27","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/ner.13480","volume":"25","author":"BE Dietz","year":"2022","unstructured":"Dietz BE, Mugan D, Vuong QC, Obara I. Electrically evoked compound action potentials in spinal cord stimulation: implications for preclinical research models. Neuromodul J Int Neuromodul Soc. 2022;25(1):64\u201374. https:\/\/doi.org\/10.1111\/ner.13480.","journal-title":"Neuromodul J Int Neuromodul Soc"}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-024-00628-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-024-00628-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-024-00628-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T08:48:28Z","timestamp":1726130908000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40122-024-00628-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,2]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["628"],"URL":"https:\/\/doi.org\/10.1007\/s40122-024-00628-z","relation":{},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"value":"2193-8237","type":"print"},{"value":"2193-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,2]]},"assertion":[{"value":"24 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Harold Nijhuis is a paid consultant for Saluda Medical, and Abbott. Harold Nijhuis has a research grant with Abbott. Willem-Jan Hofst\u00e9 is a paid consultant for Saluda Medical and Abbott. Philippa Armstrong has received travel grants and speaker fees from Saluda Medical. Johan van de Minkelis is a paid consultant for Saluda Medical. Jan Vesper is a paid consultant for Abbott, Boston Scientific, UniQure, Curonix. Jan Vesper has research grants with Abbott and Boston Scientific and is on the advisory board of Abbott. Ashish Gulve is on the advisory board for Medtronic and Boston Scientific. Ashish Gulve has a research grant with Saluda Medical. Ashish Gulve reports personal fees unrelated to the submitted work from Nevro, Medtronic, Boston Scientific and Mainstay Medical. Jan-Willem Kallewaard is on the advisory board of Saluda Medical, Medtronic, Boston Scientific and Abbott. Jan-Willem Kallewaard has research grants from Boston Scientific, Abbott, Nevro and Saluda Medical. Frank Huygen reports personal fees from Abbott, grants, personal fees from Saluda, personal fees from Boston Scientific, personal fees from Grunenthal, personal fees from Pfizer, outside the submitted work. Serge Nikolic is a paid consultant for Saluda Medical, Nevro, and Stratus Medical. Birte E. Dietz and Dave Mugan are employed by Saluda Medical. There are no other relationships that might lead to a conflict of interest in the current study. All other authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The observational data collection strictly adhered to the ethical principles outlined in the Declaration of Helsinki. In the Netherlands, prospective data collection where people are only subjected to treatment in the context of their medical condition and not treatment in the context of the study falls outside the scope of the Medical Research Involving Human Subjects Act (WMO). Consequently, no ethics committee approval was required for the Dutch centers participating in this noninterventional study, an affirmation was provided by the ethics committee (Amsterdam University Medical Centers, W17_309#17.362). The study is duly registered on the International Clinical Trials Registry Platform (Trial NL7889). In Germany, the study is duly registered as NCT05272137 and in the United Kingdom as ISCRTN27710516 and has been reviewed by the ethics committee in both countries. In accordance with the General Data Protection Regulation (GDPR), written informed consent was sought from all participating patients for the use of their data in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}